IL-27RA/TCCR hFc Chimera, Human
IL-27RA/TCCR HFc Chimera, Human

Immobilized IL-27RA/TCCR hFc Chimera, Human, hFc Tag at 5 μg/ml (100 μl/well) on the plate. Dose response curve for Human IL-27, His Tag with the EC50 of 55.9 ng/ml determined by ELISA.

IL-27RA/TCCR HFc Chimera, Human

IL-27RA/TCCR hFc Chimera, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

IL-27RA/TCCR HFc Chimera, Human

IL-27RA/TCCR hFc Chimera, Human, hFc Tag captured on CM5 Chip via Protein A can bind Human IL-27, His Tag with an affinity constant of 3.58 nM as determined in SPR assay (Biacore T200).

IL-27RA/TCCR hFc Chimera, Human

A multicenter, web-based Thyroid Cancer and Tumor Collaborative Registry (TCCR, http://tccr.unmc.edu) allows for the collection and management of various data on thyroid cancer (TC) and thyroid nodule (TN) patients. The TCCR is coupled with OpenSpecimen, an open-source biobank management system, to annotate biospecimens obtained from the TCCR subjects.
Z05489
¥63,425.00

Ask us a question
Product Introduction
Species Human
Protein Construction
IL-27RA/TCCR (Gly34-Lys516)
Accession # Q6UWB1		 hFc
N-term C-term
Purity > 95% as determined by Bis-Tris PAGE
Endotoxin Level Less than 1EU per μg by the LAL method.
Biological Activity Measured by its binding ability in a functional ELISA. Test result was comparable to standard batch.
Expression System HEK293
Theoretical Molecular Weight 79.3 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 90-120 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS, 5mM DTT (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.

Examples
  • IL-27RA/TCCR HFc Chimera, Human
    • IL-27RA/TCCR HFc Chimera, Human

    Immobilized IL-27RA/TCCR hFc Chimera, Human, hFc Tag at 5 μg/ml (100 μl/well) on the plate. Dose response curve for Human IL-27, His Tag with the EC50 of 55.9 ng/ml determined by ELISA.

  • IL-27RA/TCCR HFc Chimera, Human
    • IL-27RA/TCCR HFc Chimera, Human

    IL-27RA/TCCR hFc Chimera, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

  • IL-27RA/TCCR HFc Chimera, Human
    • IL-27RA/TCCR HFc Chimera, Human

    IL-27RA/TCCR hFc Chimera, Human, hFc Tag captured on CM5 Chip via Protein A can bind Human IL-27, His Tag with an affinity constant of 3.58 nM as determined in SPR assay (Biacore T200).


Background
Target Background A multicenter, web-based Thyroid Cancer and Tumor Collaborative Registry (TCCR, http://tccr.unmc.edu) allows for the collection and management of various data on thyroid cancer (TC) and thyroid nodule (TN) patients. The TCCR is coupled with OpenSpecimen, an open-source biobank management system, to annotate biospecimens obtained from the TCCR subjects.
Synonyms IL-27RA; TCCR; IL27RA; IL-27R-alpha; IL27R alpha; WSX-1; WSX1; ZcytoR1; CRL1; IL-27 RA; IL27 RA

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.